NCT07144813View on ClinicalTrials.gov

Post-Approval Study of the Neuspera Sacral Neuromodulation System

NANot yet recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Urinary Urgency Incontinence
Interventions
DEVICE

Neuspera Implantable Sacral Neuromodulation System

Stimulation of the Sacral Nerve.

Sponsors
All Listed Sponsors
lead

Neuspera Medical, Inc.

INDUSTRY

NCT07144813 - Post-Approval Study of the Neuspera Sacral Neuromodulation System | Biotech Hunter | Biotech Hunter